The 41 references in paper S. Avdeev N., N. Karchevskaya A., G. Baimakanova E., A. Cherniak V., С. Авдеев Н., Н. Карчевская А., Г. Баймаканова Е., А. Черняк В. (2014) “Годичное наблюдение за больными, перенесшими острое повреждение легких / острый респираторный дистресс синдром, вызванный вирусом гриппа А / H1N1 // A one-year follow-up study of patients survived after ALI / ARDS caused by influenza A / H1N1” / spz:neicon:pulmonology:y:2011:i:4:p:58-66

1
Чучалин А.Г. Тяжелые формы гриппа: диагностические и лечебные алгоритмы. Пульмонология 2009; 5: 5–7.
(check this in PDF content)
2
Ющук Н.Д., Малышев Н.А., Авдеев С.Н. и др.Исходы тяжелого течения пандемического гриппа A / H1N1 / 2009. Тер. арх. 2010; 11: 15–18.
(check this in PDF content)
3
World Health Organization. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. http://www.who.int/csr/resources/publications/swineflu/ clinical_management_h1n1.pdf
(check this in PDF content)
4
World Health Organization. Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 update. Wkly Epidemiol. Rec. 2009; 84: 305–308.
(check this in PDF content)
5
Авдеев С.Н.Пневмония и острый респираторный дистрес-синдром, вызванные вирусом гриппа А / H1N1. Пульмонология 2010; прил.: "Грипп А / H1N1: уроки пандемии": 32–46.
(check this in PDF content)
6
Perez)Padilla R., de la Rosa)Zamboni D., Ponce de Leon S. et al.Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 2009; 361: 680–689.
(check this in PDF content)
7
Jain S., Kamimoto L., Bramley A.M. et al.Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med. 2009; 361: 1935–1944.
(check this in PDF content)
8
Denholm J.T., Gordon C.L., Johnson P.D. et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med. J. Aust. 2010; 192: 84–86.
(check this in PDF content)
9
Ware L.B., Matthay M.A.Acute respiratory distress syndrome. N. Engl. J. Med. 2000; 342: 1334–1349.
(check this in PDF content)
10
Herridge M.S., Cheung A.M., Tansey C.M. et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N. Engl. J. Med. 2003; 348: 683–693.
(check this in PDF content)
11
Orme J., Romney J.S., Hopkins R.O. et al.Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2003; 167: 690–694.
(check this in PDF content)
12
Tansey C.M., Louie M., Loeb M. et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 2007; 167: 1312–1320.
(check this in PDF content)
13
Hui D.S., Joynt G.M., Wong K.T. et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a Hong Kong cohort of survivors. Thorax 2005; 60: 401–409.
(check this in PDF content)
14
Hui D.S., Wong K.T., Antonio G.E. et al.Long-term sequelae of SARS: physical, neuropsychiatric, and quality-of-life assessment. Hong Kong Med. J. 2009; 15 (Suppl. 8): S21–S23.
(check this in PDF content)
15
Bernard G.R., Artigas A., Brigham K.L. et al. The AmericanEuropean Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994; 149: 818–824.
(check this in PDF content)
16
Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 1985; 13: 818–829.
(check this in PDF content)
17
Marhsall J.C., Cook D.J., Christou N.V. et al.Multiple Organ Dysfunction Score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 1995; 23: 1638–1652.
(check this in PDF content)
18
Quanjer P.H., Tammeling G.J., Cotes J.E. Lung volumes and forced ventilatory flows. Report working party. Standardization of lung function tests. European Community for steel and coal. Official statement of the European Respiratory Society. Eur. Respir. J. 1993; 6: 5–40.
(check this in PDF content)
19
Cotes J.E., Chinn D.J., Quanjer P.H. Standardization of the measurement of transfer factor (Diffusing Capacity). Report working party, Standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur. Respir. J. 1993; 6: 41–52.
(check this in PDF content)
20
Mahler D., Weinberg D., Wells C., Feinstein A. The measurement of dyspnea: contents, interobserver agreement and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751–758.
(check this in PDF content)
21
Borg G.A. Psychophysical basis of perceived exertion. Med. Sci. Sports Exerc. 1982; 14: 377–381.
(check this in PDF content)
22
Enright P.L., Sherrill D.L. Reference equations for the sixminute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998; 158: 1384–1387.
(check this in PDF content)
23
Davidson T.A., Caldwell E.S., Curtis J.R. et al. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. J.A.M.A. 1999; 281: 354–360.
(check this in PDF content)
24
Booth C.M., Matukas L.M., Tomlinson G.A. et al.Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. J.A.M.A. 2003; 289: 2801–2809.
(check this in PDF content)
25
Lee N., Hui D., Wu A. et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003; 348: 1986–1994.
(check this in PDF content)
26
Hui D.S., Wong K.T., Ko F.W. et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005; 128: 2247–2261.
(check this in PDF content)
27
Ong K.C., Ng A.W., Lee L.S. et al. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur. Respir. J. 2004; 24: 436–342.
(check this in PDF content)
28
Tsai L.K., Hsieh S.T., Chao C.C. et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch. Neurol. 2004; 61: 1669–1673.
(check this in PDF content)
29
Herridge M.S., Tansey C.M., Matte A. et al. Functional disability 5 years after acute respiratory distress syndrome. N. Engl. J. Med. 2011; 364: 1293–1304.
(check this in PDF content)
30
Chang Y.)C., Yu C.)J., Chang S.)C. et al.Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: Evaluation with thin-section CT. Radiology 2005; 236: 1067–1075.
(check this in PDF content)
31
Naranjo T.W., Lopera D.E., Diaz)Granados L.R. et al. Combined itraconazole-pentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioidomycosis in mice. Pulm. Pharmacol. Ther. 2011; 24: 81–91.
(check this in PDF content)
32
Dixon B., Schultz M.J., Smith R. et al. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit. Care 2010, 14: R180.
(check this in PDF content)
33
Schraufstatter I.U., Revak S.D., Cochrane C.G.Proteases and oxidants in experimental pulmonary inflammatory injury. J. Clin. Invest. 1984; 73: 1175–1184.
(check this in PDF content)
34
Bunnell E., Pacht E.R.Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1993; 148: 1174–1178.
(check this in PDF content)
35
Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 2000; 16: 534–554.
(check this in PDF content)
36
MacNee W., Rahman I. Oxidants / antioxidants in idiopathic pulmonary fibrosis. Thorax 1995; 50 (Suppl. 1): S53–S58.
(check this in PDF content)
37
Cantin A.M., Hubbard R.C., Crystal R.G. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1989; 139: 370–372.
(check this in PDF content)
38
Liu R.)M., Liu Y., Forman H.J. et al.Glutathione regulates transforming growth factor-b-stimulated collagen production of fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 286: L121–L128.
(check this in PDF content)
39
Авдеев С.Н., Батын С.З., Мержоева З.М., Чучалин А.Г. Высокие дозы N-ацетилцистеина при остром респираторном дистресс-синдроме. Вестн. анестезиол. и реаниматол. 2010; 5: 3–11.
(check this in PDF content)
40
Behr J., Maier K., Degenkolb B. et al.Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 1997; 156: 1897–1901.
(check this in PDF content)
41
Demedts M., Behr J., Buhl R. et al.High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2005; 353: 2229–2242. Информация об авторах Авдеев Сергей Николаевич– д. м. н., проф., руководитель клиническо-
(check this in PDF content)